Table 5.
Correlation of expression of DcR3 and ERK1/2 with pathologic stages of tumour in gastric cancer patients
| TNM stage | Cases | Positive number | Positive rate (%) | |||||
|---|---|---|---|---|---|---|---|---|
| I |
6 |
mRNA |
Protein |
+/+ |
mRNA |
Protein |
+/+ |
|
| DcR3 |
|
1 |
1 |
1 |
16.7 |
16.7 |
16.7 |
|
| ERK1 |
|
2 |
2 |
1 |
33.3 |
33.3 |
16.7 |
P > 0.05 |
| ERK2 |
|
1 |
1 |
0 |
16.7 |
16.7 |
0.0 |
|
| II |
17 |
|
|
|
|
|
|
|
| DcR3 |
|
12 |
13 |
10 |
70.6 |
76.5 |
58.8 |
|
| ERK1 |
|
14 |
14 |
11 |
82.4 |
82.4 |
64.7 |
P > 0.05 |
| ERK2 |
|
10 |
12 |
9 |
58.8 |
70.6 |
52.9 |
|
| III |
25 |
|
|
|
|
|
|
|
| DcR3 |
|
21 |
21 |
21 |
84.0 |
84.0 |
84.0 |
|
| ERK1 |
|
23 |
24 |
22 |
92.0 |
96.0 |
88.0 |
P > 0.05 |
| ERK2 |
|
20 |
23 |
18 |
80.0 |
92.0 |
72.0 |
|
| IV |
2 |
|
|
|
|
|
|
|
| DcR3 |
|
2 |
2 |
2 |
100.0 |
100.0 |
100.0 |
|
| ERK1 |
|
2 |
2 |
2 |
100.0 |
100.0 |
100.0 |
P > 0.05 |
| ERK2 | 1 | 1 | 1 | 50.0 | 50.0 | 50.0 | ||